204 related articles for article (PubMed ID: 24183083)
1. [Hormonal treatment in prostate cancer].
Bastide C; Bruyère F; Karsenty G; Guy L; Rozet F
Prog Urol; 2013 Nov; 23(15):1246-57. PubMed ID: 24183083
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer and new hormonal treatments: mechanism of action and main clinical results].
Neuzillet Y; Flamand V; Lebdai S; Villers A; Lebret T
Prog Urol; 2013 Oct; 23 Suppl 1():S34-43. PubMed ID: 24314737
[TBL] [Abstract][Full Text] [Related]
3. [Significance of neoadjuvant therapy for prostate cancer].
Okada K; Hachiya T
Nihon Hinyokika Gakkai Zasshi; 1997 Sep; 88(9):769-77. PubMed ID: 9364842
[No Abstract] [Full Text] [Related]
4. [Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives].
Pinto F; Calarco A; Totaro A; Sacco E; Volpe A; Racioppi M; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):71-83. PubMed ID: 20890863
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
6. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
7. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K
Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic drugs.
McLeod DG
Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
[TBL] [Abstract][Full Text] [Related]
9. Hormonal therapy of prostate cancer.
Debruyne F
Semin Urol Oncol; 2002 Aug; 20(3 Suppl 1):4-9. PubMed ID: 12198632
[TBL] [Abstract][Full Text] [Related]
10. First-line treatment of metastatic prostate cancer. Androgen suppression for symptomatic disease.
Prescrire Int; 2013 Feb; 22(135):48-51. PubMed ID: 23444510
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal therapy for prostatic cancer--state of the art].
Miyakita H
Nihon Rinsho; 2005 Feb; 63(2):305-8. PubMed ID: 15714983
[TBL] [Abstract][Full Text] [Related]
12. [Keyrole of endocrinology in the victory against prostate cancer].
Labrie F
Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
[TBL] [Abstract][Full Text] [Related]
13. Initiation of LHRH monotherapy for prostate cancer.
Milsted RA
Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
[No Abstract] [Full Text] [Related]
14. Prostate cancer. Primary hormonal treatment.
Denis L
Cancer; 1993 Feb; 71(3 Suppl):1050-8. PubMed ID: 8428327
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Bollack C; Rougeron G
Am J Clin Oncol; 1988; 11 Suppl 2():S156-9. PubMed ID: 2977270
[TBL] [Abstract][Full Text] [Related]
16. Antiandrogens as monotherapy for prostate cancer.
Schröder FH
Eur Urol; 1998; 34 Suppl 3():12-7. PubMed ID: 9854190
[TBL] [Abstract][Full Text] [Related]
17. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy in advanced prostate cancer: an overview.
Baltogiannis D; Giannakopoulos X; Charalabopoulos K; Sofikitis N
Exp Oncol; 2004 Sep; 26(3):185-91. PubMed ID: 15494685
[TBL] [Abstract][Full Text] [Related]
19. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy.
Migliari R; Muscas G; Murru M; Verdacchi T; De Benedetto G; De Angelis M
Arch Ital Urol Androl; 1999 Dec; 71(5):293-302. PubMed ID: 10673793
[TBL] [Abstract][Full Text] [Related]
20. [First line therapy in the treatment of metastatic prostate cancer].
Sakai H; Kanetake H
Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
